°å³ØÀìÌç¤Î¿Þ½ñ½ÐÈǼҡ¢°å³Ø½ñ¤Î¥ª¥ó¥é¥¤¥óÈÎÇä¤ò¹Ô¤¦Àèü°å³Ø¼Ò¤Î¥¦¥§¥Ö¥µ¥¤¥È¤Ç¤¹¡£

 

¥È¥Ã¥× > ¥Ð¥Ã¥¯¥Ê¥ó¥Ð¡¼ > ʬ»Ò¥ê¥¦¥Þ¥Á¼£ÎÅ > ʬ»Ò¥ê¥¦¥Þ¥Á¼£ÎÅ 2019ǯ8·î¹æ (Vol.12 No.3)

ʬ»Ò¥ê¥¦¥Þ¥Á¼£ÎÅ 2019ǯ8·î¹æ (Vol.12 No.3)

¢£ÊÔ½¸¼ç´´
½»ÅÄ¡¡¹§Ç·:ÃÞÇÈÂç³Ø°å³Ø°åÎÅ·ÏÆâ²Ê(籸¶É¡¦¥ê¥¦¥Þ¥Á¡¦¥¢¥ì¥ë¥®¡¼)¶µ¼ø
¢£ÊÔ½¸´´»ö
ÌÚ¼¡¡Í§¸ü:ÉÙ»³Âç³ØÂç³Ø±¡°å³ØÌô³Ø¸¦µæÉôÀ°·Á³°²Ê¡¦±¿Æ°´ïɳضµ¼ø
ÃÝÆâ¡¡¡¡¶Ð:·Ä±þµÁ½ÎÂç³Ø°å³ØÉôÆâ²Ê³Ø¶µ¼¼¥ê¥¦¥Þ¥Á籸¶ÉÂÆâ²Ê¶µ¼ø
»³ËÜ¡¡°ìɧ:Íý²½³Ø¸¦µæ½êÅý¹çÀ¸Ì¿°å²Ê³Ø¸¦µæ¥»¥ó¥¿¡¼Éû¥»¥ó¥¿¡¼Ä¹

  • A4Ƚ/60ÊÇ
  • 2019ǯ7·îȯ¹Ô
¾¦ÉÊ¥³¡¼¥É : 978-4-86550-403-3
²Á³Ê : 2,530±ß¡ÊÀǹþ¡Ë
¿ôÎÌ
 

10,000±ß(Àǹþ¤ß)°Ê¾å¤ÇÁ÷ÎÁ̵ÎÁ ¡¡

¤«¤´¤ËÆþ¤ì¤ë ¤¹¤°¤Ë¹ØÆþ
  • ¤ªµ¤¤ËÆþ¤ê¥ê¥¹¥È
  • ¾¦ÉʤˤĤ¤¤Æ¤ÎÌ䤤¹ç¤ï¤»

¢£Æý¸:¾®»ù¥ê¥¦¥Þ¥ÁÀ­¼À´µ¤ÎTransition
¡½¾®»ù¥ê¥¦¥Þ¥Á°å¤¬Æâ²Ê/À°·Á¥ê¥¦¥Þ¥Á°å¤Ë·Ò¤²¤¿¤¤¤³¤È

¾®»ù¥ê¥¦¥Þ¥ÁÀ­¼À´µ¤Î´µ¼Ô¤Î¿¤¯¤¬¼£ÎŤò·Ñ³¤·¤Ê¤¬¤éÀ®¿Í´ü¤ò·Þ¤¨¤ë¡£¤³¤Î°Ü¹Ô´ü´Ö¤ÎÌäÂê¤Ë¤ï¤¬¹ñ¤ÎÆñÉÂÀ©ÅÙ¤¬¼è¤êÁȤߡ¢¾®»ùËýÀ­ÆÃÄê¼Àɼ£ÎŸ¦µæ»ö¶È(¾®Ëý)¤ÈÆñÉÂÂкö»ö¶È(»ØÄêÆñÉÂ)¤ÎÁê¸ß¾è¤êÆþ¤ì¤¬¿Ê¤á¤é¤ì¤¿¡£°ìÊý¤ÇÂбþ¤¬ÃÙ¤ì¤Æ¤¤¤¿°åÎŦ¤Ç¤â¡¢´Ø·¸½ô³Ø²ñ¤Ë¤ª¤¤¤Æ¥¹¥à¡¼¥º¤Ç¥·¡¼¥à¥ì¥¹¤Ê°Ü¹Ô´ü°åÎŤμ¸½¤Ë¸þ¤±¤Æ³èÆ°¤¬¤Ï¤¸¤Þ¤Ã¤Æ¤¤¤ë¡£¥ê¥¦¥Þ¥Á¼À´µ¤ò¿Ç¤ë°åÎżԤËÀ§Èó¤È¤âƧ¤Þ¤¨¤Æ¤ª¤¤¤Æ¤¤¤¿¤À¤­¤¿¤¤»ö¹à¤¬ËþºÜ¤Ç¤¢¤ë¡£

¢£Æý¸:¾®»ù¥ê¥¦¥Þ¥ÁÀ­¼À´µ¤ÎTransition
¡½¾®»ù¥ê¥¦¥Þ¥Á°å¤¬Æâ²Ê/À°·Á¥ê¥¦¥Þ¥Á°å¤Ë·Ò¤²¤¿¤¤¤³¤È
   ¼ãǯÀ­ÆÃȯÀ­´ØÀá±ê¤Ë¤Ä¤¤¤ÆÃΤäƤª¤¯¤Ù¤­¤³¤È¤Ï? ²¬ËÜ¡¡ÆàÈþ
   ¾®»ùÁ´¿ÈÀ­¥¨¥ê¥Æ¥Þ¥È¡¼¥Ç¥¹(SLE)
   ¡½À®¿ÍSLE¤È²¿¤¬°ã¤¦¤«? Éð°æ¡¡½¤¼£
   ¼ãǯÀ­ÈéÉæ¶Ú±ê:À®¿ÍÈéÉæ¶Ú±ê¤È²¿¤¬°ã¤¦¤Î¤«? Ãݺê½Ó°ìϺ¤Û¤«
   ¥·¥§¡¼¥°¥ì¥ó¾É¸õ·²¤ÎÉÂÂÖ²òÌÀ¤Ë¤Ï¾®»ù´µ¼Ô¤Î
   Å¬ÀڤʿÇÃǤÈĹ´ü¥Õ¥©¥í¡¼¤¬½ÅÍפǤ¢¤ë ÉÚÈÄÈþÆà»Ò
   ¼«¸Ê±ê¾ÉÀ­¼À´µ¤Î¸½¾õ¤Èº£¸å¤Ë¸þ¤±¤¿Äó°Æ À¾¾®¿¹Î´ÂÀ
   ¾®»ù¥ê¥¦¥Þ¥ÁÀ­¼À´µ¤Î°Ü¹Ô»Ù±ç¤Î¸½¶·¤È²ÝÂê¤Ï²¿¤«? µÜÁ°Â¿²Â»Ò
¢£Ï¢ºÜ ¥ê¥¦¥Þ¥ÁÀ­¼À´µ¤ÎÆñ¼£À­ÉÂÂ֤μ£ÎÅ[Âè18²ó]
   ¹âÎð´ØÀá¥ê¥¦¥Þ¥Á ¶âÅļ¡¡Ä¾¿Í
¢£Ï¢ºÜ ¹üÂå¼Õ¡¦¹üÌȱÖ[Âè21²ó]
   »õ¼þɤÎÌȱֳء¦¹üÂå¼Õ³Ø ±§ÅÄÀǷ¤Û¤«
¢£Ï¢ºÜ ÉÔÌÀÇ®¤Î¸¶°ø¤È¤Ê¤ë¥ê¥¦¥Þ¥ÁÀ­¼À´µ[Âè6²ó]
   Á´¿ÈÀ­¥¨¥ê¥Æ¥Þ¥È¡¼¥Ç¥¹ °ìÀ¥¡¡Ë®¹°
¢£Ï¢ºÜ ÌȱֳؤÎABC[Âè12²ó]
   CD28¥Õ¥¡¥ß¥ê¡¼Ê¬»Ò¤Ë¤è¤ëTºÙ˦¤Î³èÀ­²½À©¸æ ¼ã¾¾¡¡¡¡±Ñ¤Û¤«
¢£Journal Club
   ¡ûEctopic germinal center—like structures in minor salivary 
   gland biopsy tissue predict lymphoma occurrence in patients
   with primary Sjögren¡Çs syndrome.
   Sjögren¡Çs syndrome.
   ¡ûJAK—1 inhibition suppresses interferon—induced BAFF production
   in human salivary gland:potential therapeutic strategy for primary
   Sjögren¡Çs syndrome. ¾®Àî¡¡Ë¡ÎÉ
   ¡ûCRISPR—Cas9 targeting of MMP13 in human chondrocytes
   leads to significantly reduced levels of the metalloproteinase
   and enhanced type­¶ collagen accumulation.
   ¡ûMicrobiota—dependent involvement of Th17 cells in murine 
   models of inflammatory arthritis. Ã漡¡¡¡ÍÎ
   ¡ûA randomized, controlled double—blind study comparing the
   efficacy and safety of dose—ranging voclosporin with placebo 
   in achieving remission in patients with active lupus nephritis.
   ¡ûDevelopment and validation of a renal risk score in ANCA
   —associated glomerulonephritis. ºäÆþ¡¡¡¡Å°¤Û¤«
   ¡ûMonoclonal antibody targeting BDCA2 ameliorates skin lesions 
   in systemic lupus erythematosus.
   ¡ûBeyond autoantibodies:biologic roles of human autoreactive
   B cells in rheumatoid arthritis revealed by RNA—sequencing. Æ£°æ¡¡Çî»Ê
¡ü¥¨¥Ã¥»¥¤¡Ø»ä¤È¥ê¥¦¥Þ¥Á³Ø¡Ù ¸ÅÀî¡¡Ê¡¼Â

¥Ú¡¼¥¸¥È¥Ã¥×¤Ø